Distribution Deal
IRVINE — Endocare Inc. signed an eight-year agreement with Boston Scientific Corp., which will distribute Endocare’s Cryocare surgical system for the treatment of prostate disease. Financial terms were not disclosed.
Cryosurgery is an alternative surgical method to freeze and destroy targeted tissues through a minimally invasive procedure.
Endocare develops, manufactures and markets medical devices used in the treatment of prostate diseases.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
